Increased circulating transforming growth factor β1 in a patient with giant hepatic hemangioma: Possible contribution to an impaired immune function

Hepatology

Volumn 25, Issue 1, 1997, Pages 93-96

  Ito, Nobuyuki ^a   Kawata, Sumio ^a   Tsushima, Hirofumi ^a   Tamura, Shinji ^a   Kiso, Shinichi ^a   Takami, Shigeki ^a   Igura, Takumi ^a   Monnden, Morito ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; LIVER HEMANGIOMA; NORTHERN BLOTTING; PRIORITY JOURNAL;

EID: 0031021279     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250117     Document Type: Article

References (36)

1. Feldman M. Hemangioma of the liver. Special reference to its association with cysts of the liver and pancreas. Am J Clin Pathol 1958;29:160-162.
2. Ishak KG. Mesenchymal tumors of the liver. In: Okuda K, Peters RL, eds. Hepatocellular Carcinoma. New York: Wiley, 1976;247-307.
3. Adam YG, Huvos AG, Fortner JG. Giant hemangioma of the liver. Ann Surg 1970;172:239-245.
4. Berliner L, el Ferzli G, Gianvito L, Worth MH Jr, Lowry J, Redmond P, Silich R. Giant cavernous hemangioma of the liver complicated by abscess and thrombosis. Am J Gastroenterol 1983;78:835-840.
5. Sewell JH, Weiss K. Spontaneous rupture of hemangioma of the liver. Arch Surgery 1962;83:729-733.
6. Kasabach HH, Merritt KK. Capillary hemangioma with extensive purpura. Am J Dis Child 1940;59:1063-1070.
7. Grieco MB, Miscall BG. Giant hemangiomas of the liver. Surg Gynecol Obstet 1978;47:783-787.
8. Kehrl JH, Roberts AB, Wakefield LM, Jakowlew S, Sporn MB, Fauci AS. Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J Immunol 1986;137:3855-3860.
9. Kehrl JH, Taylor AS, Delsing GA, Roberts AB, Sporn MB, Fauci AS. Further studies of the role of transforming growth factor β in human B cell function. J Immunol 1989;143:1868-1874.
10. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, Sporn MB, et al. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986;163:1037-1050.
11. Rook AH, Kehrl JH, Wakefield LM, Roberts AB, Sporn MB, Burlington DB, Lane HC, et al. Effect of transforming growth factor β on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 1986;136:3916-3920.
12. Geller RL, Smyth MJ, Strobl SL, Bach FH, Ruscetti FW, Longo DL, Ochoa AC. Generation of lymphokine-activated killer activity in T cells. J Immunol 1991;146:3280-3288.
13. Arteaga CL, Hurd SD, Winnier AR, Johnson MD, Fendly BM, Forbes T. Anti-transforming growth factor (TGF)-β antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. J Clin Invest 1993;92:2569-2576.
14. Johnson CM, Sheedy PFII, Stanson AW, Stephens DH, Hattery RR, Adson MA. Computed tomography and angiography of cavernous hemangiomas of the liver. Radiology 1981;138:115-121.
15. 1 in patients with hepatocellular carcinoma: comparison with chronic liver diseases. Cancer 1994;73:2275-2279.
16. Roberts AB, Lamb LC, Newton DL, Sporn MB, De Larco JE, Todaro GJ. Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc Natl Acad Sci U S A 1980;77:3494-3498.
17. 1 in renal cell carcinoma. Cancer Res 1989;49:6972-6975.
18. Yoshida K, Yokozaki H, Niimoto M, Ito H, Ito M, Tahara E. Expression of TGF-β and procollagen type I and type III in human gastric carcinomas. Int J Cancer 1989;44:394-398.
19. Ito N, Kawata S, Tamura S, Takaishi K, Shirai Y, Kiso S, Yabuuchi I, et al. Elevated levels of transforming growth factor β messenger RNA and its polypeptide in human hepatocellular carcinoma. Cancer Res 1991;51: 4080-4083.
20. 1 levels with tumor vascularity in hepatocellular carcinoma. Cancer Lett 1995;89: 45-48.
21. Lee G, Ellingsworth LR, Gillis S, Wall R, Kincade PW. Beta transfomring growth factors are potential regulators of B lymphopoiesis. J Exp Med 1987;166:1290-1297.
22. Smeland EB, Blomhoff HK, Holte H, Ruud E, Beiske K, Funderud S, Godal T, et al. Transforming growth factor type beta (TGF beta) inhibits G1 to S transition, but not activation of human B lymphocytes. Exp Cell Res 1987;171:213-222.
23. Bartlett WC, Purchio A, Fell HP, Noelle RJ. Cognate interactions between helper T cells and B cells. VI. TGF-β inhibits B cell activation and antigen-specific, physical interactions between Th and B cells. Lymph Cytokine Res 1991;10:177-183.
24. Coffman RL, Lebman DA, Schrader B. Transforming growth factor specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J Exp Med 1989;170:1039-1044.
25. 1 increases IgA isotype switching at the clonal level. J Immunol 1990;145:3773-3778.
26. Tsunawaki S, Sporn MB, Ding A, Nathan C. Deactivation of macrophages by transforming growth factor-β. Nature 19881;334:260-262.
27. Jin B, Scott JL, Vadas MA, Burns GF. TGF-β down-regulates TLiSA1 expression and inhibits the differentiation of precursor lymphocytes into CTL and LAK cells. Immunology 1989;66:570-576.
28. + T cell function. Jpn J Cancer Res 1993;84:315-325.
29. 1. J Exp Med 1990; 172:1777-1784.
30. 1 inhibits murine immediate and delayed hypersensitivity. J Immunol 1992;149:521-528.
31. Sporn MB, Roberts AB, Wakefield LM, Assoian RK. Transforming growth factor β: biological function and chemical structure. Science 1986;233:532-534.
32. Knabbe C, Lippman ME, Wakefield LM. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 1987;48:417-428.
33. Kositchek RJ, Cullen RA. Hemangiomatosis of the liver with thrombosis following use of an oral contraceptive. California Medicine 1970;113:70-74.
34. Morley JE, Myers JB, Sack FS, Kalk F, Epstein EE, Lannon J. Enlargement of cavernous haemangioma associated with exogenous administration of oestrogens. South African Medical Journal 1974;48:695-697.
35. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, et al. Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A 1986;83:4167-4171.
36. 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 1990;111:731-741.